Wainzua 45 mg solution for injection in pre-filled pen
*Company:
AstraZeneca Pharmaceuticals (Ireland) DACStatus:
NewLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 29 April 2026
File name
20260126 Package Leaflet IE MT Wainzua PFP 45mg Shelf life update CV 26 0002.pdf
Reasons for updating
- New PIL for new product
Updated on 29 April 2026
File name
20260126 SPC IE MT Wainzua PFP 45mg shelf life update CV 26 0001.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
AstraZeneca Pharmaceuticals (Ireland) DAC
 DAC.webp)
Address:
College Business and Technology Park, Blanchardstown Road North, Dublin 15, D15 R925Medical Information E-mail:
mipqc.ireland@astrazeneca.comTelephone:
+353 1 609 7100Fax:
+353 1 686 5038Website:
https://contactazmedical.astrazeneca.comMedical Information Direct Line:
1800800899